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This study aimed to test pharmaceutical compounds targeting astrocytes showing inﬂammatory dys-
regulation. The primary rat brain cultures were treated with different batches of serum with or without
microglia added to make the cells inﬂammatory-reactive. Lipopolysaccharide (LPS) and tryptase were
used as inﬂammatory inducers. Expression levels of Toll-like receptor 4 (TLR4), Naþ/Kþ-ATPase, and
matrix metalloprotease-13 (MMP-13), as well as actin ﬁlament organization, pro-inﬂammatory cyto-
kines, and intracellular Ca2þ release, were evaluated. LPS combined with tryptase upregulated TLR4
expression, whereas Naþ/Kþ-ATPase expression was downregulated, ATP-evoked Ca2þ transients were
increased, actin ﬁlaments were reorganized and ring structures instead of stress ﬁbers were observed.
Other aims of the study were to prevent astrocytes from becoming inﬂammatory-reactive and to restore
inﬂammatory dysregulated cellular changes. A combination of the m-opioid antagonist ()-naloxone in
ultra-low concentrations, the non-addictive m-opioid agonist ()-linalool, and the anti-epileptic agent
levetiracetam was examined. The results indicated that this drug cocktail prevented the LPS- and
tryptase-induced inﬂammatory dysregulation. The drug cocktail could also restore the LPS- and tryptase-
treated cells back to a normal physiological level in terms of the analyzed parameters.
© 2016 The Author(s). This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Inﬂammatory cells are important contributors to the patho-
physiological response to injury. Penetration through the bloode-
brain barrier (BBB) is achieved by circulating bone-marrow-derived
leukocytes or monocytes, which can transform into macrophages/
microglia. These cells secrete cytokines that promote tissue damage
(Medzhitov, 2008; Waisman et al., 2015). The BBB consists of
capillary endothelial cells containing specialized tight junctions
and surrounded by a basement membrane, which is composed of
extracellular matrix components, pericytes and astrocytic peri-
vascular endfeet (Abbott et al., 2006). The gram-negative bacterial
endotoxin lipopolysaccharide (LPS) induces the conversion of
endothelial cells into activated ﬁbroblasts that show aNeuroscience, Institute of
y, University of Gothenburg,
en.
Hansson).
ess article under the CC BY-NC-NDmyoﬁbroblast-like protein proﬁle. This process is mediated by the
Toll-like receptor 4 (TLR4)/NF-kB pathway (Sarmiento et al., 2014).
Astrocytes are now known to exert either potent pro-
inﬂammatory functions or crucial protective anti-inﬂammatory
functions that are regulated by speciﬁc signaling inputs (Hansson,
2010; Zeng et al., 2013; Hansson and Ski€oldebrand, 2015). Their
processes establish contacts with the BBB and the processes of
other astrocytes via gap junctions, thereby forming networks of
coupled astrocytes (Cornell-Bell et al., 1990; Blomstrand et al.,1999;
Guthrie et al., 1999; Nedergaard et al., 2003). At sites of CNS tissue
damage, astrocytes become reactive and form scar borders, which
serve as functional barriers and have the potential to release
diverse molecules that affect nearby cells. Astrocyte dysfunction
can be caused by genetic polymorphisms or by exposure to mo-
lecular signals derived from infections or trauma, which can alter
astrocyte inﬂammatory regulation and lead to detrimental effects
(Sofroniew, 2015), including the alteration of astrocyte signaling
mechanisms (Hansson, 2010, 2015).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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to give good results (Forshammar et al., 2011; Block et al., 2012,
2013). However, better inﬂammatory-induced activity is desired
as the mechanisms of actions in the restoration processes are
desired to be better expressed.
Mast cells are derived from the bone marrow and play impor-
tant roles in inﬂammation, immune responses and tissue repair.
They circulate in an immature form until they reach the target
tissue site (Skaper et al., 2013). Mast cells are rich in proteases,
tryptases and chymases, as well as cytokines such as interleukins,
TGFb and tumor necrosis factor-a (TNF-a). They contact only blood
vessels that are ensheathed by astroglial processes, and they can
alter the BBB permeability and pass into the CNS (Kahli et al., 2007;
Dong et al., 2014). They can upregulate purinergic receptors on
astrocytes (Dong et al., 2014) and activate the G protein-coupled
protease-activated receptor (PAR-2) in astrocytes by releasing
tryptase (Zeng et al., 2013).
Matrix metalloproteinases (MMPs or matrixins) activate signal
transduction pathways that control cytokine biosynthesis and
barrier immunity. MMP-13, which is produced by both neurons and
astrocytes, is upregulated in response to inﬂammation in the brain,
and it remodels the extracellular matrix and degrades substrates as
part of the neuroinﬂammatory response (Cuadrado et al., 2009).
The ﬁrst aim of the present study was to test different sub-
stances of relevance to get astrocytes more inﬂammatory reactive
compared to LPS-induced inﬂammatory-reactivity. The astrocyte
cultures were treated with different batches of serum with or
without microglia. Furthermore, LPS and tryptase were applied in
combination. Cellular changes were analyzed according to several
parameters, such as expression of TLR4, Naþ/Kþ-ATPase, and MMP-
13, as well as actin ﬁlament organization, pro-inﬂammatory cyto-
kine levels, and intracellular Ca2þ release. The second aims were to
1) prevent astrocytes from becoming inﬂammatory-reactive and 2)
restore cellular changes and disturbances, which already were
inﬂammatory-reactive back to physiological levels. We have earlier
shown that a combination of a m-opioid receptor antagonist in
ultra-low concentrations, naloxone, a m-opioid agonist,
endomorphin-1, and an agent attenuating IL-1b release, levetir-
acetam, can restore cellular parameters induced by inﬂammation.
The responses have been tested in astrocytes (Block et al., 2013) and
in post-surgical neuropathic pain patients in vivo (Block et al.,
2015). We wanted now to replace endomorphin-1/morphine with
the non-addictive m-opioid agonist ()-linalool and evaluate if this
substance had similar restorative effects as endomorhin-1.
2. Materials and methods
The studies were carried out in accordance with the National
Institute of Health Guide for the Care and Use of Laboratory Animals
(NIH Publications No. 80-23) revised 1996 or the UK Animals
(Scientiﬁc Procedures) Act 1986 and associated guidelines, or the
European Communities Council Directive of 24 November 1986
(86/609/EEC).
2.1. Primary astrocyte cultures and treatments
Primary cortical astrocytes, from Sprague-Dawley rats at em-
bryonic day 19, were purchased from Invitrogen (Thermo Fisher
Scientiﬁc, Waltham, MA, USA) and prepared according to the
manufacturer's instructions with some modiﬁcations. Brieﬂy, one
vial containing 1  106 viable cells were plated at a seeding density
of 1  104 cells per cm2 on uncoated glass coverslips (no. 1, 20 mm
in diameter) (Bergman Labora, Stockholm, Sweden) and placed in
12-well plates. The medium was replaced twice per week. The as-
trocytes were used after 16e17 days in culture.2.2. Chemicals
All chemicals were obtained from Sigma-Aldrich (St. Louis, MO,
USA) unless otherwise stated.
2.3. Inﬂammatory-reactive substances added to astrocyte cultures
Cultures were treated with two different batches of serum: 15%
fetal bovine serum from Invitrogen, called astroglia serum, or 15%
fetal bovine serum (Biochem AG, Berlin, Germany) called microglia
serum, as it was used to increase the amount of microglia (Persson
et al., 2005). Some cultures were shaken to promote growth of
microglia. Exogenous microglia were added to the astrocyte
cultures.
LPS (10 ng/ml) (Forshammar et al., 2011), which was used to
promote inﬂammatory reactivity, was added 24 h before the ex-
periments. To further increase the inﬂammatory reactivity, tryptase
(10 ng/ml) (Zeng et al., 2013) was added together with LPS 24 h
before the experiments.
2.4. Immunocytochemistry
Immunocytochemistry was done according to Block et al.
(2013). Glial ﬁbrillary acidic protein (GFAP) (Dako, Glostrup,
Denmark) and a mouse monoclonal antibody against OX42 (Sero-
tec, Oxford, UK) were used. The cells were viewed using a Nikon
Eclipse 80i microscope. Pictures were taken with a Hamamatsu
C5810 color-intensiﬁed 3CCD camera.
2.5. Viability assay
A LIVE/DEAD viability assay kit (Invitrogen Molecular Probes)
for mammalian cells was used according to Forshammar et al.
(2011). viewed using a Nikon Eclipse 80i microscope. Pictures
were taken with a Hamamatsu C5810 color-intensiﬁed 3CCD.
2.6. Calcium imaging
Calcium imaging was done as earlier described (Block et al.,
2013). The total areas under the curve (AUC), which reﬂects the
amount of Ca2þ released (Berridge, 2007), were analyzed. The
amplitude was expressed as the maximum increase of the 340/380
ratio. The area under the Ca2þ peaks (AUC) was calculated in Origin
(Microcal Software Inc., Northampton, MA, USA). Forty cells were
used for each experimental set-up and were taken from four
different coverslips and from two different seeding times.
2.7. SDS-PAGE and western blot
SDS-page and western blot were done as earlier described
(Block et al., 2013).
2.8. Actin visualization
The astrocyte cytoskeleton was stained using Alexa™488-
conjugated phalloidin (Invitrogen) (Block et al., 2013).
2.9. Actin assay
Actin quantitation was performed as recommended by the F-
actin/G-actin In Vivo Assay Biochem Kit (Cytoskeleton, Inc., Denver,
CO, USA) and SDS-page performed as described above, with the
exception of the sample preparation. The primary antibody, rabbit
polyclonal anti-actin (Cytoskeleton, 1:500), and the secondary
antibody, HRP-conjugated donkey anti-rabbit IgG F(ab0)2 fragments
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2.10. Cytokine release
Rat IL-1b (R&D Systems, Oxon, UK) and TNF-a (Becton Dick-
inson, NJ, USA) were used to measure the amounts of cytokines via
ELISA according to the manufacturer's instructions.
2.11. Protein determination
A protein determination assay was performed in accordance
with the manufacturer's instructions using a detergent-compatible
(DC) Protein Assay (Bio-Rad, Hercules, CA, USA) and based on the
method used by Lowry et al. (1951).
2.12. Statistics
Statistical signiﬁcance was determined using Student's paired t-
test or one-way analysis of variance (ANOVA) followed by Dunnett's
multiple comparisons test. The error bars represent the standard
error of the mean (SEM).
3. Results
3.1. Activation of astrocytes to become inﬂammatory-reactive
3.1.1. Different batches of serum and/or addition of microglia
The results show that cultivating the astrocytes used in the
present experiments, which is cells bought from a company, in
different serum batches or shaking the cultures in different ways to
stimulate microglia growth did not increase the inﬂammatory
reactivity as evaluated with the present parameters. This was,
however, not the case with our previous astrocytes made by our-
selves (Hansson et al., 1984). Furthermore, addition of external
microglia to the present astrocyte cultures did not increase the
inﬂammatory reactivity of the astrocytes.
In all further experiments, the cells were cultivated with
astroglia serum without the addition of exogenous microglia.
3.1.2. Astrocytes incubated with LPS or LPS and tryptase
Cultures were stained for OX42, a marker for microglial cells,
and for GFAP, amarker for astrocytes. Very few or nomicrogliawere
found in the control cultures or in cultures treated with LPS for 24 h
or with LPSþ tryptase for 24 h (Fig. 1). Therewere small differences
among the groups in the viability of the cells visualized with a LIVE/
DEAD kit (Fig. 2).
Astrocyte cultures were incubated with LPS for 24 h. They
showed an increase in TLR4 expression (P< 0.05) (Fig. 3), a decrease
in Naþ/Kþ-ATPase expression (P < 0.05) (Fig. 4), and no change inFig. 1. Culture stained for OX42, a marker for microglial cells (green), and for GFAP, a ma
Similarly, very few microglia were found after treatment with LPS for 24 h or with C. LPS þMMP-13 expression (Fig. 5). Furthermore, the cells were stimulated
with ATP (104 M), which increased the ATP-evoked Ca2þ tran-
sients, AUC, (P < 0.001) (Fig. 6). The astrocytes were stained with an
Alexa488-conjugated phalloidin probe. The untreated cultures
were dominated by F-actin organized in stress ﬁbers (control). The
cultures incubated with LPS showed a more diffuse organization of
actin ﬁlaments, and the ring structures were more pronounced
(Fig. 7). They also showed morphologic changes, including the
retraction of cell bodies and changes in the stress ﬁber distribution.
Therefore, the F/G actin ratio was calculated, and it was increased in
the cells treated with LPS (P < 0.01) (Fig. 9).
Astrocyte cultures were incubated with LPS þ tryptase for 24 h.
They showed an increase in TLR4 expression (P < 0.05) (Fig. 3), a
decrease in Naþ/Kþ-ATPase expression (P < 0.01) (Fig. 4), and no
change in MMP-13 expression (Fig. 5). Furthermore, when the cells
were stimulated with ATP (104 M), the ATP-evoked Ca2þ tran-
sients increased, AUC, (P < 0.01) (Fig. 6). The cells changed their
morphology in comparison to astrocytes incubated with only LPS
(Fig. 7), and the F/G actin ratio was increased in the cells treated
with LPS and tryptase (P < 0.001) (Fig. 9).
None of the above combinations showed release of IL-1b or TNF-
a.3.2. Prevent LPS- and tryptase-induced biochemical changes in
astrocytes with the combination of ()-naloxone, ()-linalool and
levetiracetam
Astrocyteswere incubatedwith a cocktail of naloxone (1012M),
()-linalool (106 M), and levetiracetam (104 M) for 30 min. The
incubation continued with the cocktail and LPS or with the cocktail
and LPS þ tryptase for 24 h. The TLR4 expression was decreased
when incubated with the cocktail, which showed the same
expression level as the control cells. The cocktail prevented the cells
to become inﬂammatory-reactive. The Naþ/Kþ-ATPase expression
was increased, whereas MMP-13 expression did not change (Fig. 8).
The F/G actin ratio was calculated and was increased in the cells
treated with LPS (P < 0.01) or LPS þ tryptase (P < 0.001) but was
decreased in the presence of the cocktail (Fig. 9). The actin ﬁla-
ments were prevented from reorganization.3.3. Restore LPS- and tryptase-induced biochemical changes in
astrocytes with the combination of ()-naloxone, ()-linalool and
levetiracetam
Astrocytes were incubated with LPS þ tryptase for 24 h. Then,
the incubation continued with LPS þ tryptase and the cocktail of
naloxone (1012 M), ()-linalool (106 M), and levetiracetam
(104 M) for an additional 24 h. The expression levels of TLR4, Naþ/
Kþ-ATPase, and MMP-13 were then analyzed (Fig. 10). The cocktail
restored the increased expression of TLR4 to the control level. Arker for astrocytes (red). A. Very few microglia were found in the control cultures. B.
tryptase for 24 h. Scale bar ¼ 50 mm. Representative images are presented.
Fig. 2. Cell viability was visualized with Calcein AM (green) using a LIVE/DEAD kit and showed very few dead cells, shownwith red nuclei in ﬁgure (A). The viability did not change
after incubation with LPS (B) or with LPS and tryptase (C). Scale bar ¼ 50 mm. Representative images are presented.
Fig. 3. TLR4 expression. Astrocytes were incubated with LPS (10 ng/ml) for 24 h or with
LPS (10 ng/ml) and tryptase (100 ng/ml) for 24 h. The expression of TLR4 was increased
compared with the control. The level of signiﬁcance was analyzed using a one-way
ANOVA followed by Dunnett's multiple comparisons test. *P < 0.05. n ¼ 5.
Fig. 4. Naþ/Kþ-ATPase expression. Astrocytes were incubated with LPS (10 ng/ml) for
24 h or with LPS (10 ng/ml) and tryptase (100 ng/ml) for 24 h. The Naþ/Kþ-ATPase
expression was decreased compared with the control. The level of signiﬁcance was
analyzed using a one-way ANOVA followed by Dunnett's multiple comparisons test.
*P < 0.05. **P < 0.01. n ¼ 5.
Fig. 5. MMP-13 expression. Astrocytes were incubated with LPS (10 ng/ml) for 24 h or
with LPS (10 ng/ml) and tryptase (100 ng/ml) for 24 h. The MMP-13 expressionwas not
signiﬁcantly changed. The level of signiﬁcance was analyzed using a one-way ANOVA
followed by Dunnett's multiple comparisons test. n ¼ 5.
Fig. 6. ATP-evoked Ca2þ transients. All astrocytes were stimulated in a Ca2þ imaging
system. The cells were incubated with a Ca2þ-sensitive ﬂuorophore probe (Fura-2/AM).
ATP (104 M) elicited Ca2þ responses in the astrocytes and was used as the control. The
area under the Ca2þ peak (AUC) was calculated for each Ca2þ transient. The cells
incubated with LPS (10 ng/ml) for 24 h showed increased Ca2þ signaling, as did the
cells incubated with LPS (10 ng/ml) and tryptase (100 ng/ml) for 24 h. The level of
signiﬁcance was analyzed using a one-way ANOVA followed by Dunnett's multiple
comparisons test. **P < 0.01, ***P < 0.001. n ¼ 5.
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Fig. 7. Actin ﬁlaments. Astrocytes were stained with Alexa488-conjugated phalloidin. A. The untreated cells were dominated by F-actin organized in stress ﬁbers (control). B. The
cells incubated with LPS (10 ng/ml) for 24 h showed a more diffuse organization of actin ﬁlaments, and the ring structures were more pronounced. C. The cultures incubated with
LPS (10 ng/ml) and tryptase (100 ng/ml) for 24 h showed an even more diffuse organization than LPS-treated cells. Scale bar ¼ 50 mm. Representative images are presented.
Fig. 8. Prevent LPS- and tryptase-induced biochemical changes in astrocytes with the combination of ()-naloxone, ()-linalool and levetiracetam. Astrocytes were incubated with a
cocktail of naloxone (1012 M), ()-linalool (106 M), and levetiracetam (104 M) for 30 min. Then, the incubation continued with the cocktail and LPS (10 ng/ml), þ tryptase
(100 ng/ml) for 24 h. The expression levels of TLR4, Naþ/Kþ-ATPase and MMP-13 were studied using western blot analysis. The level of signiﬁcance was analyzed using one-way
ANOVA followed by Dunnett's multiple comparisons test. *P < 0.05, ***P < 0.001, n.s. ¼ non-signiﬁcant. n ¼ 4.
Fig. 9. Actin ﬁlaments. Astrocytes were incubated with a cocktail of naloxone (1012 M), -()linalool (106 M), and levetiracetam (104 M) for 30 min. Then, the incubation
continued with the cocktail and LPS (10 ng/ml) (A), or the cocktail and LPS þ tryptase (100 ng/ml) for 24 h (B). The F/G actin ratio was measured. The result showed that the ratio
was increased in the cells treated with LPS and LPS þ tryptase, and decreased when the cells were pretreated with the cocktail. The level of signiﬁcance was analyzed using one-way
ANOVA followed by Dunnett's multiple comparisons test. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. ¼ non-signiﬁcant. n ¼ 4.
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did not change. The F/G actin ratio was calculated and was
increased in the cells treated with LPS (P < 0.05) and LPS þ tryptase
(P < 0.001) compared to their respective controls. The cocktail
decreased the ratio back to the control level (Fig. 11).3.3.1. Glutamate-evoked Ca2þ responses were increased with LPS
and attenuated by the combination of naloxone, ()-linalool and
levetiracetam
Glutamate (104 M) was used as a stimulator in the Ca2þ im-
aging experiments, in which all cells responded (n ¼ 40). The AUC
was calculated for each condition (Fig. 12).Astrocytes incubated with LPS for 24 h showed an increase in
glutamate-evoked Ca2þ signaling compared with controls (gluta-
mate stimulation alone). The AUC was increased (P < 0.001). All
cells responded, n ¼ 40 (Fig. 12). The cells were incubated with LPS
(10 ng/ml) for 24 h, and then ()-naloxone (1012 M), ()-linalool
(106 M), and levetiracetam (104 M) were applied 3.5 min before
glutamate stimulation. Notably, the glutamate-upregulated Ca2þ
increase was not attenuated by ()-linalool alone, ()-naloxone
alone or combined with ()-linalool, or levetiracetam alone.
However, the combination of ()-naloxone, ()-linalool, and lev-
etiracetam (cocktail) attenuated the glutamate signaling (P < 0.05),
and all cells responded (Fig. 12). The present results have to be
compared with the results in Block et al. (2013), where the cocktail
Fig. 10. Restore LPS- and tryptase-induced biochemical changes in astrocytes with the combination of ()-naloxone, ()-linalool and levetiracetam. Astrocytes were incubated with LPS
(10 ng/ml) þ tryptase (100 ng/ml) for 24 h. Then, the cells were incubated with LPS þ tryptase and the cocktail of naloxone (1012 M), ()-linalool (106 M), and levetiracetam
(104 M) for an additional 24 h. The expression levels of TLR4, Naþ/Kþ-ATPase and MMP-13 were studied using western blot analysis. The level of signiﬁcance was analyzed using
one-way ANOVA followed by Dunnett's multiple comparisons test. *P < 0.05, ***P < 0.001, n.s. ¼ non-signiﬁcant. n ¼ 4.
Fig. 11. Actin ﬁlaments. Astrocytes were incubated with LPS (10 ng/ml) (A) or LPS þ tryptase (100 ng/ml) (B) for 24 h. Then, the incubation continued with LPS and the cocktail of
naloxone (1012 M), ()-linalool (106 M), and levetiracetam (104 M) for an additional 24 h (A), or with LPS þ tryptase and the cocktail for an additional 24 h (B). The F/G actin ratio
was measured. The ratio was increased in the cells treated with LPS and tryptase but decreased when the cells were stimulated with the cocktail. The level of signiﬁcance was
analyzed using one-way ANOVA followed by Dunnett's multiple comparisons test. *P < 0.05, ***P < 0.001, n.s. ¼ non-signiﬁcant. n ¼ 4.
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sults show that endomorphin-1 can be replaced by the non-
addictive m-agonist ()-linalool.
4. Discussion
Inﬂammation in the CNS differs from inﬂammation elsewhere in
the body because of the sensitivity and isolation of the CNS.
Microglia produce anti-inﬂammatory and neurotrophic factors
under physiological conditions and produce pro-inﬂammatory
mediators in response to infection or tissue damage (Streit,
2002). They act on astrocytes that in turn amplify the inﬂamma-
tory reaction (Saijo et al., 2009). Therefore, microglia and astrocytes
are of particular interest because both cell types can initiate and
amplify inﬂammation and thereby release neurotoxic compounds.
Therefore, an in vitro cell model system of inﬂammation is desir-
able for studying potential treatments, which is even better than
the one used by us in earlier experiments (Block et al., 2013).
The astrocyte cultures were investigated using different culti-
vation parameters. Two different fetal calf sera were used to pro-
mote microglial growth. Furthermore, the cultures were shaken to
recruit more microglia. Microglia from external cultures were also
added. We hypothesized that the number of microglia and/or the
reactivity of these cells could make the astrocytes inﬂammatory-
reactive (DeLeo et al., 2004; Milligan and Watkins, 2009). Our re-
sults show that astrocytes and microglia are not capable of initi-
ating inﬂammation by themselves, but microglia do appear to be atleast partly responsible for the changes induced in known bio-
markers, with a stronger induction of TLR4 and reduced expression
of Naþ/Kþ-ATPase, but without the release of pro-inﬂammatory
cytokines.
Previous studies have produced inﬂammatory-reactive astro-
cytes with LPS or IL-1b (Forshammar et al., 2011; Lundborg et al.,
2011; Block et al., 2012). Mast cells are active in vivo during
inﬂammation and release serine proteases such as tryptase
(Medzhitov, 2008). Therefore, we expanded our inﬂammatory po-
tential combining LPS with tryptase. The tryptase-activated re-
ceptor 2 (PAR-2) is well known to be widely expressed on
astrocytes and to play a major role in inﬂammation (Zeng et al.,
2013).
TLRs, which recognize structural motifs that are characteristic of
pathogens and which are expressed by innate immune cells
(Janeway and Medzhitov, 2002), are gaining increasing recognition
for their roles in several inﬂammatory diseases. LPS has been
shown to be an agonist for TLR4 (Qureshi et al., 1999), which is
thought to be largely responsible for LPS-related signaling (Kielian,
2006). It has been proposed that TLRs drive inﬂammation that gives
rise to detectable symptoms (O'Neill, 2003; Krasowska-Zoladek
et al., 2007). Astrocytes express TLR4, which is further induced
after incubation with LPS (Forshammar et al., 2011) or with the
combination of LPS and tryptase.
Three Naþ ions are required for the uptake of one glutamate, and
this transport is dependent on the intra- and extracellular concen-
trations of Naþ (Longuemare et al., 1999). The intracellular
Fig. 12. Glutamate-evoked Ca2þ transients. All astrocytes were stimulated in a Ca2þ
imaging system. The cells were incubated with a Ca2þ-sensitive ﬂuorophore (Fura-2/
AM). Glutamate (104 M) elicited Ca2þ responses in the astrocytes and was used as a
control. The area under the Ca2þ peak (AUC) was calculated for each Ca2þ transient.
The cells incubated with LPS (10 ng/ml) for 24 h showed increased Ca2þ signaling. The
cells incubated with LPS (10 ng/ml) for 24 h and then ()-naloxone (1012 M),
()-linalool (106 M), levetiracetam (104 M), or a combination of the three substances
was applied 3.5 min before glutamate stimulation. ()-linalool alone, ()-naloxone
alone or together with ()-linalool, or levetiracetam alone did not attenuate the
glutamate-upregulated Ca2þ transients. The combination of ()-naloxone, ()-linalool,
and levetiracetam (cocktail) attenuated the glutamate signaling. The level of signiﬁ-
cance was analyzed using a one-way ANOVA followed by Dunnett's multiple com-
parisons test. *P < 0.05, ***P < 0.001, n.s. ¼ non-signiﬁcant. n ¼ 5.
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dependent on ATP (Longuemare et al., 1999). The present study
showed a decrease in Naþ/Kþ-ATPase expression, whichwas further
decreased after the combined treatment with LPS and tryptase.
No changes were observed in the expression of the latent pro-
enzyme form of MMP-13, and no active form of MMP-13 was
detected.
In conditions that lead to chronic neuroinﬂammation, Ca2þ
signaling in astrocyte networks is overactivated (Hansson, 2010,
2015; Forshammar et al., 2011). Regulation of Ca2þ dynamics by
transmitters and soluble factors is a possible mechanism by which
the astrocyte networks detect changes in the CNS microenviron-
ment and regulate brain activity, such as inﬂammatory processes.
LPS changed the ATP-evoked Ca2þ transients with increased
intracellular Ca2þ release. Intercellular Ca2þ communication takes
place through gap junctions, and the parallel system for intercel-
lular Ca2þ communication between astrocytes occurs via extracel-
lular communication through the diffusion of ATP (Fields and
Burnstock, 2006). ATP then binds to purinoceptors, speciﬁcally
P2Y-receptors, which leads to an overstimulation of the Gq protein,
and subsequent elevations of intracellular Ca2þwaves are observed
(Blomstrand et al., 1999).
Cells treated with LPS or LPS þ tryptase displayed reorganiza-
tion of their stress ﬁbers and induced formation of ring structures
that resulted in an increased F/G actin ratio, which was also
conﬁrmed using phalloidin staining. Reorganization of F-actin into
different contractile structures such as apical rings, vacuoles, or
stress ﬁber-like cables that are more or less diffuse was observed in
our previous study (Hansson, 2015), as well as in epithelial cells
(Ivanov et al., 2010), pulmonary monocytes (Du et al., 2012), and
vascular smooth muscle cells (Kim et al., 2008).A cocktail of naloxone, ()-linalool and levetiracetam was used
for two purposes. First, to prevent network-coupled astrocytes
from becoming inﬂammatory-reactive. Second, to restore already
inﬂammatory-reactive networks.
Naloxone, a non-selective m-opioid antagonist, and a ()-isomer,
normally blocks the Gi/Go protein associated with the m-opioid
receptor. However, in ultra-low concentrations, naloxone blocks
the Gs protein instead (Block et al., 2012). Chronic morphine
administration decreases Gi/Go protein coupling and increases
coupling to the Gs protein. This phenomenon has been observed in
cultured dorsal root ganglion neurons (Crain and Shen, 1995), rat
brain organotypic cultures (Wang and Burns, 2009), in vivo in rats
(Wang et al., 2005), and in patients treated for low back pain (Block
et al., 2015). Ultra-low concentrations of naloxone can block the Gs
protein, and morphine or another m-opioid receptor agonist can
thereby stimulate the Gi/Go protein (Block et al., 2013; Hansson,
2015). However, it is worth knowing that another form of
naloxone exists. The inactive (þ)-isomer of naloxone, which has no
antagonistic effects on opioid receptors, has been shown to be an
antagonist of TLR4 and to block the downstream signaling leading
to the production of nitric oxide (NO), TNF-a and reactive oxygen
species (ROS) (Wang et al., 2015).
An important aim with the present study was to replace
endomorphin-1/morphine with a non-addictive m-opioid agonist
(Block et al., 2013). Linalool, (3,7-dimethyl-1,6-octadien-3-ol), a
monoterpene, along with its naturally occurring enantiomer
()-linalool, possesses anti-inﬂammatory activity, as well as anti-
hyperalgesic and anti-nociceptive effects, which are reversed by
naloxone and the unselective muscarinic receptor antagonist
atropine (Peana et al., 2003, 2006). Furthermore, linalool attenu-
ated the LPS-induced production of TNF-a and IL-6 (Huo et al.,
2013). The present results show that ()-linalool has the same
qualities as the previously used m-opioid receptor agonists.
Levetiracetam has showed to be an effective anti-epileptic drug,
and it has also been proved to restore disturbed gap junction
coupling in inﬂammation-reactive astrocyte cultures (Stienen et al.,
2010) by increasing connexin 43 expression, the predominant gap
junction protein, and to decrease the enhanced production of IL-1b
level (Haghikia et al., 2008). The cellular functions of astrocytes in
an inﬂammatory state were virtually restored with the combina-
tion of linalool, naloxone and levetiracetam to their normal non-
inﬂammatory states. The present results were comparable with
the results by Block et al. (2013), where endomorphin-1, naloxone
and levetiracetam were used.
The present results show that the cocktail of naloxone, linalool
and levetiracetam has effects promoting the prevention of and
recovery from inﬂammatory reactivity in astrocytes. The three
substances in the cocktail affect the cells in different ways. One
substance alone has no chance. We previously identiﬁed the pa-
rameters of the mechanisms underlying or contributing to neuro-
inﬂammation (Block et al., 2013; Hansson, 2015). TLR4 is attacked
by LPS, and changes in Naþ/Kþ-ATPase seem to be important, as
well as Ca2þ signaling in the astrocyte networks, cytokine release
and actin ﬁlament reorganization. Most parameters were restored
to normal physiological levels by the cocktail. The next challenge
was to determine whether the astrocyte networks could be
restored once they had become inﬂammatory-reactive upon
treatment with LPS þ tryptase. Even in this condition, most of the
parameters were restored to normal physiological levels by the
cocktail.
Glutamate-evoked intracellular Ca2þ release was studied with a
Ca2þ imaging system. Glutamate stimulates the astrocytes to
release Ca2þ, which is further increased with LPS. The single sub-
stances in the cocktail released Ca2þ at the same level as glutamate
but the challenge was to further decrease the intracellular evoked
E. Hansson et al. / IBRO Reports 1 (2016) 1e98Ca2þ release. Glutamate is a transmitter with inﬂammatory prop-
erties (Hansson, 1994; Hansson et al., 1994; Milligan and Watkins,
2009). Therefore we reasoned that a further decrease might be of
importance. These results were obtained with endomorphin-1 in
the cocktail (Block et al., 2013) and with ()-linalool in the cocktail
in the present study.
The next questions and challenges are, of course, whether the
cocktail has anti-inﬂammatory or restorative effects in humans. We
have used an ultra-low dose of intrathecal naloxone in addition to
intrathecal morphine infusion in patients with severe, persistent
pain, which improved the perceived quality of sleep and where
conventional pain therapies are insufﬁcient. We were not able to
show any statistically signiﬁcant effects of naloxone on pain relief
due to the short treatment time and a small sample size; however,
some of the patients in the group reported pain relief (Block et al.,
2015; Block, 2016). The next step is to evaluate the present phar-
maceutical combination in patients with chronic inﬂammation and
longterm pain for longer time than previously done. Substantial
progress has been made in understanding how chronic systemic
low-grade inﬂammation inﬂuences the physiology of several dis-
eases such as neuroinﬂammation, neurodegenerative diseases,
osteoarthritis, metabolic, cardiac inﬂammation and autoimmune
diseases, but not why it fails to be resolved (Lecuyer et al., 2016).
The physiological nature of inﬂammation has been gaining ground
as a key contributor and search for inﬂammatory markers has
increased. Inﬂammation requires contribution from other tissue
cells such as gap junction coupled cells (Hansson and Ski€oldebrand,
2015).
Conclusion: Inﬂammatory reactivity in astrocytes was achieved
with a combination of LPS and tryptase. The pharmaceutical com-
pounds, ()-linalool, naloxone in ultra-low concentrations, and the
anti-epileptic agent levetiracetam, which target dysregulated
cellular mechanisms in astrocytes, showed the ability to both
prevent and restore inﬂammatory reactivity. This combination of
drugs represents an interesting and new way to inﬂuence and
restore cellular parameters changed due to inﬂammation.Conﬂict of interest
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